Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Profound Medical (PROF) Accumulated Depreciation & Amortization (2018 - 2026)

Profound Medical has reported Accumulated Depreciation & Amortization over the past 8 years, most recently at $1.6 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 33.43% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, down 33.43%, while the annual FY2025 figure was $1.6 million, 33.43% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $1.6 million at Profound Medical, down from $1.6 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $2.4 million in Q4 2024 and troughed at $994000.0 in Q4 2021.
  • A 5-year average of $1.8 million and a median of $1.8 million in 2025 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 215.8% in 2021 and later crashed 33.43% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $994000.0 in 2021, then surged by 48.69% to $1.5 million in 2022, then soared by 49.93% to $2.2 million in 2023, then increased by 7.85% to $2.4 million in 2024, then tumbled by 33.43% to $1.6 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for PROF at $1.6 million in Q4 2025, $1.6 million in Q3 2025, and $1.9 million in Q2 2025.